Las Vegas, NV -- (SBWIRE) -- 01/23/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: DryShips Inc.(NASDAQ:DRYS), Magnum Hunter Resources Corp(NYSE:MHR), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), SUPERVALU INC.(NYSE:SVU)
DryShips Inc.(NASDAQ:DRYS) was a volume gainer of 5.66 million shares and the average volume of the stock remained 17.78 million shares. The stock opened the session at $3.81 and finished at the end of the day at $3.81.The market capitalization of the stock remained 1.54 billion. DryShips Inc. owns drybulk carriers and tankers that operate worldwide. DryShips Inc. owns a fleet of 42 drybulk carriers comprising 12 Capesize, 28 Panamax, and 2 Supramax with a combined deadweight tonnage of approximately 4.4 million tons; and 10 tankers comprising 4 Suezmax and 6 Aframax with a combined deadweight tonnage of approximately 1.3 million tons.
Can DRYS Show a Strong Recovery? Find out in This Research Report
In the preceding trading session, Magnum Hunter Resources Corp(NYSE:MHR) exchanged 5.33 million shares and the average volume remained 4.12 million shares. The stock closed the session at $8.73 with the gain of 3.19%. Magnum Hunter Resources Corporation, an independent oil and gas company, engages in the exploration, exploitation, acquisition, development, and production of crude oil, natural gas, and natural gas liquid resources in the United States and Canada. Magnum Hunter Resources Corporation was incorporated in 1997 and is headquartered in Houston, Texas.
Will MHR Continue To Move Higher? Find Out Here
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) enhanced 2.32% and its closing price was $7.49. The volume of the stock was 5.21 million shares and the average volume remained 5.37 million shares. The market capitalization of the stock remained 1.64 billion. The beta of the stock remained -0.40. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After The Recent Gain? Just Go Here and Find Out
SUPERVALU INC.(NYSE:SVU) exchanged 4.78 million shares in the previous trading session, and its average trading remained 4.45 million shares. SVU dropped -1.91% and it closed the trading at $6.15. The market capitalization of the stock remained 1.60 billion. SUPERVALU INC., together with its subsidiaries, operates as a wholesale distributor to independent retail customers in the United States. It operates in three segments: Retail Food, Save-A-Lot, and Independent Business.
Has SVU Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/">http://www.equityobserver.com/&l...; employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/>
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)